Enzyme may hold key to new treatment of diabetic kidney disease
Researchers at Northwestern University have discovered an enzyme called ACE2 that may hold the potential to treat diabetic kidney disease. Studies suggest that increasing ACE2 levels in the kidneys could reverse or prevent kidney disease from developing.
SourceNorthwestern University·JournalClinical Journal of the American Society of Nephrology·DateNov 7, 2006